Hill Holliday has promoted David Leonardi to chief creative officer of its health care practice, Hill Holliday Health. He will be reporting into Icaro Doria, North American chief creative officer, Hill Holliday. This is one of Doria’s first executive moves, since joining Hill Holliday in January of 2021. Leonardi joined Hill Holliday Health as executive creative director in 2013 with over 15 years of experience on such consumer health brands as LIPITOR®, Prevacid®, SPIRIVA®, and LAP-BAND®.
“Over the past decade, our healthcare expertise has grown quietly yet tremendously, driving results for some of the biggest names in the industry,” said Doria. “David has been a huge part of that growth, I have full faith in his creative vision, his goals for further growth, and I look forward to working with him to create brave, ambitious, and culturally relevant ideas for our health clients going forward.”
Leonardi added, “I’m grateful for the opportunity to work alongside Icaro–an amazing creative leader and person–to help him create the next chapter in Hill Holliday’s storied history. There’s an intangible quality and commitment with everyone here at Hill Holliday Health; our collective passion to help people is real. We use every ounce of that to create work that breaks through, builds client business and helps change—or even save—lives.”
Hill Holliday Health has experienced impressive growth after launching its healthcare practice bringing on four new client companies and seven new brands in CNS, oncology, women’s healthcare, and ophthalmology. Hill Holliday Health’s clients include J&J, Lundbeck, Regeneron, and Intra-Cellular Therapies.
